◆
Triple receptor action targets GLP-1, GIP, and glucagon simultaneously for unmatched metabolic control.
Metabolic · Body Recomposition
Retatrutide
The most powerful body recomposition peptide in existence.
GLP-1GIPGlucagon
PROTOCOL BENEFITS
Engineered Outcomes
Appetite controlBody recompositionVisceral fat
◆
Rewrites your metabolic blueprint with fat loss, muscle preservation, and appetite regulation in one protocol.
◆
Research shows significant reduction in body weight and visceral fat across study models.
SCIENCE
How It Works.
Retatrutide is a triple agonist peptide, activating GLP-1, GIP, and glucagon receptors at once. Most metabolic peptides target one. Retatrutide targets all three simultaneously.
Unlike compounds that only suppress appetite, Retatrutide works at the hormonal level to mobilize fat stores, preserve lean tissue, and recalibrate metabolic set points.
WHAT TO EXPECT
Results are progressive. Most research models show measurable metabolic changes within 4-6 weeks, with significant body composition shifts at 8-12 weeks.
PROTOCOL NOTE
Available in 10mg and 20mg. For research use only. Full usage documentation included with every order.
PROTOCOL COMPARISON
Research Snapshot
| Primary pathway | Triple agonist |
|---|---|
| Research focus | GLP-1, GIP, glucagon |
| Observed window | 4-12 weeks |
| Available variants | 10mg, 20mg |
FAQ
Protocol Questions
What makes Retatrutide different from single-pathway metabolic peptides?+
Retatrutide is positioned around simultaneous GLP-1, GIP, and glucagon receptor activity, giving the protocol a broader metabolic research profile.
When do research models typically show measurable change?+
Most research models show measurable metabolic changes within 4-6 weeks, with larger body composition changes developing around 8-12 weeks.
RELATED PRODUCTS